GlassScriptPhysician profile
Eunjae Lee
NPI 1093384042
$595.68
in general payments reported to CMS, 2019-2025
12 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.02 · 2022: $75.28 · 2023: $135 · 2024: $209 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $114.90 | 2025 | Uplizna |
| Abbvie INC. | $101.30 | 2021-2023 | |
| Coopersurgical, INC. | $89.73 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $54.92 | 2023-2024 | Veozah |
| Shield Therapeutics INC | $46.13 | 2024 | |
| Davol INC. | $40.01 | 2024-2025 | Arista |
| Organon LLC | $33.57 | 2022-2024 | |
| Intuitive Surgical, INC. | $31.37 | 2024 | |
| Astellas Pharma Global Development | $28.48 | 2024 | Veozah |
| Mayne Pharma Commercial LLC | $24.70 | 2023 | |
| Medtronic, INC. | $16.43 | 2022 | |
| Sumitomo Pharma America, INC. | $14.14 | 2024 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eunjae Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.